Early diagnosis and intensive treatment to maintain optimal glycaemic control reduce the
morbidity and mortality associated with type 2 diabetes. To sustain glucose concentrations as
near normal as possible — and make the Quality and Outcomes Framework diabetes targets
achievable — generally requires use of more than one antidiabetic agent, which necessitates
attention to licensing indications, as Dr Caroline Day explains.